CFDE Data Portal | Search ECEL1P2

	Label	Description
	ECEL1P2 associations Collection (Entity type)	Associations for ECEL1P2_associations
	ECEL1P2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	ECEL1P2 Gene (Entity type)	ENSG00000224516 - endothelin converting enzyme like 1 pseudogene 2
	GSE214931 temozolomide 4 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE164529 tamoxifen 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 7 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE195764 GSE195816 EBF1 knockdown 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 6 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 3 v 9 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE244730 erlotinib PC-9 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

ECEL1P2 associations

Associations for ECEL1P2_associations

ECEL1P2 associations.tsv

A file from IDG as part of the Harmonizome project

ECEL1P2

ENSG00000224516 - endothelin converting enzyme like 1 pseudogene 2

GSE214931 temozolomide 4 v 0 human up

A Gene Set from LINCS

GSE164529 tamoxifen 0 v 1 human up

A Gene Set from LINCS

GSE239844 crizotinib 7 v 0 human up

A Gene Set from LINCS

GSE195764 GSE195816 EBF1 knockdown 2 v 3 human dn

A Gene Set from LINCS

GSE239844 crizotinib 6 v 0 human up

A Gene Set from LINCS

GSE216043 cisplatin 3 v 9 human dn

A Gene Set from LINCS

GSE244730 erlotinib PC-9 0 v 1 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.